The Medicines CompanyMDCO announced an agreement with Tokyo based specialty pharmaceutical company, SymBio Pharmaceuticals Ltd., under which SymBio will have an exclusive license to develop and commercialize Ionsys (fentanyl iontophoretic transdermal system) in Japan. The deal with SymBio will